![David Gobel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 365 $ al 31/08/2026
Mr. David Gobel is an Independent Director at VivoSim Labs, Inc., a Chairman at Turn Biotechnologies, Inc., a Chief Executive Officer at Methuselah Capital Management LLC, a Chief Executive Officer at Methuselah Funds LLC, an Independent Director at Oisin Biotechnologies, Inc. and a Chief Executive Officer at Methuselah Foundation.
He is on the Board of Directors at VivoSim Labs, Inc., Leucadia Therapeutics, Inc. and Oisin Biotechnologies, Inc. Mr. Gobel was previously employed as a Chief Venture Strategist by Transportation Security Administration.
He also served on the board at Volumetric Biotechnologies, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VIVOSIM LABS INC 0,58 % | 13/08/2026 | 15.000 ( 0,58 % ) | 4 365 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VIVOSIM LABS, INC. | Director/Miembro de la Junta | 15/09/2020 |
Oisin Biotechnologies, Inc.
 Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Provides biological solutions to degenerative aging conditions | Director/Miembro de la Junta | 01/12/2014 |
Methuselah Capital Management LLC
 Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management invests in companies located in the United States. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements. | Director Ejecutivo | 01/01/2017 |
Leucadia Therapeutics, Inc.
 Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic algorithm for alzheimer disease prevention and treatment | Director/Miembro de la Junta | 01/10/2015 |
Methuselah Foundation
 Methuselah Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a biomedical charity which focuses on human lifespan and improving longevity | Director Ejecutivo | 01/09/2001 |
Turn Biotechnologies, Inc.
 Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Presidente | 01/05/2020 |
Methuselah Funds LLC
 Methuselah Funds LLC Investment ManagersFinance Acts as Venture Capital Fund | Director Ejecutivo | 01/12/2016 |
| Empresas | Cargo | Fin |
|---|---|---|
Volumetric Biotechnologies, Inc. | Director/Miembro de la Junta | 01/01/2020 |
Transportation Security Administration
 Transportation Security Administration General GovernmentGovernment Operates and manages transportation security system | Corporate Officer/Principal | 01/03/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
VivoSim Labs, Inc.
 VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
Transportation Security Administration
Transportation Security Administration General GovernmentGovernment Operates and manages transportation security system | Government |
Methuselah Foundation
Methuselah Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a biomedical charity which focuses on human lifespan and improving longevity | Miscellaneous |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Provides biological solutions to degenerative aging conditions | Health Technology |
Methuselah Funds LLC
Methuselah Funds LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management invests in companies located in the United States. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements. | Finance |
Leucadia Therapeutics, Inc.
Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic algorithm for alzheimer disease prevention and treatment | Health Technology |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Technology Services |
Volumetric Biotechnologies, Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
